| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL2101101 | 人血管性血友病因子 | Other | Biological Products(3.2) | New Drug Application | 2021-06-02 | China Resources Boya Bio-pharmaceutical Group Co Ltd | view | ||||
| CXSL1900029 | 人血管性血友病因子 | Other | Biological Products(7) | New Drug Application | 2019-03-27 | 山东泰邦生物制品有限公司 | Shandong Taibang Biological Products Co Ltd | In Review | 2019-03-26 | view |